Update on Biosimilar Insulins: A US Perspective.

BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
Rong M ZhangJanet B McGill

Abstract

The development of biosimilar insulin products has slowly evolved with only two follow-on biologics currently available to patients in the US. Both Basaglar® (insulin glargine) and Admelog® (insulin lispro) have undergone extensive testing, and have gained significant use by patients in the US. Despite the availability of these follow-on products, the price of insulin has remained stubbornly high. New regulatory guidance under the Biologics Price Competition and Innovations Act that came into effect in March 2020 introduced an abbreviated pathway for the approval of biosimilar insulins and introduced the option to apply for interchangeability of the biosimilar insulin with the reference product. This abbreviated clinical testing may open the doors for numerous follow-on insulin products, with unknown supply-chain and fiscal ramifications. This review will highlight the development process of biosimilar insulin in the US and the recent regulatory changes that can aid this process. We will also discuss challenges for prescribers and patients who are navigating this ever-changing landscape. These new regulations for biosimilar insulins will have ramifications for patients, healthcare providers, and third-party payers, though the d...Continue Reading

References

Oct 28, 2003·Diabetes Care·Matthew C RiddleUNKNOWN Insulin Glargine 4002 Study Investigators
Apr 6, 2016·JAMA : the Journal of the American Medical Association·Xinyang HuaPhilip Clarke
Dec 1, 2017·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Vivian A FonsecaGuillermo E Umpierrez
Mar 24, 2018·Diabetes Care·UNKNOWN American Diabetes Association
Aug 21, 2018·The Annals of Pharmacotherapy·Jack T Rasmussen, Heather J Ipema
Sep 8, 2018·JAMA : the Journal of the American Medical Association·Jinoos YazdanyChien-Wen Tseng
Jan 4, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Robyn K PollomRamón Ortiz Carrasquillo
Feb 11, 2020·The Annals of Pharmacotherapy·Jamie M PitlickKatlynn Wellington

❮ Previous
Next ❯

Citations

Nov 3, 2021·Journal of Managed Care & Specialty Pharmacy·Jentora WhiteHima Patel

❮ Previous
Next ❯

Software Mentioned

Humalog
SORELLA
Admelog

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Diabetes Spectrum : a Publication of the American Diabetes Association
Anne Park Kim, Ross Jason Bindler
Diabetic Medicine : a Journal of the British Diabetic Association
M DaviesC Mathieu
Journal of Diabetes Science and Technology
Mukul Minocha, Jogarao Gobburu
Journal of Diabetes Science and Technology
L Heinemann, David Owens
Current Medical Research and Opinion
Steven V EdelmanChristopher G Parkin
© 2021 Meta ULC. All rights reserved